Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
FDA: Knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
CNN2 天
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo ...
Potential 'fungal contamination' leads to nationwide recall of popular brand of eye drops: FDA
A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Malaysia Sun23 小时
Knockoff versions of Lilly obesity drug must be off shelves: FDA
FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...
US FDA says Lilly's weight-loss drug shortage is resolved
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly's blockbuster weight loss ...